Medical Technology Stock News - Neovasc (NASDAQ: NVCN) Announces FDA Approval of COSIRA-II Clinical Trial

Media coverage

• Title	Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
  Media name/outlet	Asian Hospital & Healthcare Management
  Country/Territory	India
  Date	17/09/21
  URL	https://www.asianhhm.com/pressreleases/neovasc-announces-fda-approval-of-cosira-ii-clinical-trial
  Persons	Gregg Stone

• Title	Medical Technology Stock News - Neovasc (NASDAQ: NVCN) Announces FDA Approval of COSIRA-II Clinical Trial
  Media name/outlet	MENAFN - Business & Finance News (English)
  Country/Territory	Jordan
  Date	16/09/21
  Persons	Gregg Stone